Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

8.63
-0.1000-1.15%
Post-market: 8.880.2500+2.90%16:56 EDT
Volume:235.52K
Turnover:2.04M
Market Cap:2.69B
PE:25.46
High:8.84
Open:8.75
Low:8.54
Close:8.73
Loading ...

Stock Track | Alvotech Plummets 5.80% Pre-Market on Wider-than-Expected 2024 Loss Despite Revenue Growth

Stock Track
·
27 Mar

Exchange-Traded Funds Decline, Equity Futures Mixed Pre-Bell Thursday Ahead of Slew of Economic Data

MT Newswires Live
·
27 Mar

BRIEF-Alvotech Appoints Dr. Balaji V. Prasad As Chief Strategy Officer

Reuters
·
27 Mar

Alvotech Appoints DR. Balaji V. Prasad as Chief Strategy Officer

THOMSON REUTERS
·
27 Mar

Press Release: Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer

Dow Jones
·
27 Mar

Alvotech 2024 Loss Narrows, Revenue Increases

MT Newswires Live
·
27 Mar

Alvotech FY 2024 GAAP EPS $(0.87) Misses $(0.55) Estimate, Sales $492.00M Beat $455.53M Estimate

Benzinga
·
27 Mar

Alvotech SA reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

Alvotech Reports Record Results for 2024 and Provides Business Update

THOMSON REUTERS
·
27 Mar

Alvotech FY Product Revenue USD 273.472 Million

THOMSON REUTERS
·
27 Mar

Press Release: Alvotech Reports Record Results for 2024 and Provides Business Update

Dow Jones
·
27 Mar

BRIEF-Alvotech SA MHRA Accepts Marketing Application For AVT23 Biosimilar To Xolair

Reuters
·
26 Mar

Alvotech, Partners Say UK Regulator Accepted Market Application for Proposed Xolair Biosimilar

MT Newswires Live
·
26 Mar

Alvotech Sa - Mhra Accepts Marketing Application for Avt23 Biosimilar to Xolair

THOMSON REUTERS
·
26 Mar

Alvotech SA expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
25 Mar

Icelandic Biotech Company Alvotech to Explore Listing in Stockholm

Dow Jones
·
20 Mar

Alvotech Expands with Acquisition of Xbrane’s R&D Operations

TIPRANKS
·
20 Mar

Alvotech to Acquire Xbrane Biopharma's R&D Operations, Biosimilar Candidate

MT Newswires Live
·
20 Mar

Alvotech Sa - Acquisition Valued at Approximately SEK 275 Million (USD 27 Million)

THOMSON REUTERS
·
20 Mar

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms Its Global Leadership Position in Biosimilars Development and Production

THOMSON REUTERS
·
20 Mar